Health Condition 1: B369- Superficial mycosis, unspecified
Conditions
Interventions
Intervention1: LUCRUSH (LULICONAZOLE 1% W/W CREAM): Thin film to be applied on the affected area and some of the surrounding skin. Gently rub in as directed once a day.
One time application
Sponsors
Dr Reddys Laboratories Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Clinically Diagnosed patients with cutaneous mycosis who are prescribed LUCRUSH as per physicianâ??s discretion
Exclusion criteria
Exclusion criteria: Investigatorâ??s discretion to not to include patients such as of Patients requiring systemic antifungal drugs, pregnant or lactating women, or patients with any significant medical illness such as diabetes, immunocompromised conditions, and other sexually transmitted diseases, etc. Hypersensitivity to Luliconazole based formulation Multiple topical antifungal usage Topical steroid based formulation usage Oral antihistamine usage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in itch severity as assessed on 10-point VASTimepoint: 2 min, 5 min, 10 min, 1 hour, 4-hour, 8-hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Number & Type of adverse events during treatment with LucrushTimepoint: 2 min, 5 min, 10 min, 1 hour, 4-hour, 8-hour;Number of patients achieved all night relief from itching by self-assessment questionnaire.Timepoint: 2 min, 5 min, 10 min, 1 hour, 4-hour, 8-hour | — |
Countries
India
Contacts
Public ContactAkhila Paspulate
Dr. Reddys Laboratories Ltd.
Outcome results
None listed